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An intercomparison exercise was conducted for the quantification ofarsenic species in spiked
human urine. Theprimaryobjectiveofthe exercisewas todetermine thevarianceamong labora-
tories in the analysis ofarenicspecies such asinorganicAs (As.3 andAs5), monomethylarsonic
acid (MMA), anddimethylarsinic add (DMA). Laboratories thatparicipated hadprevious ep-
riencewith arsenic speciation analysis. Theresults oftisinterlaboratorycomparison are encour-
aging. There is relavely agreement on the concenraons ofthese areic sp in urine
atconcentrations that are relevantto research on the metabolism ofarsenic inhumans andother
mammals. Both the accuracy and precision are relatively poor for arsenic concentrations ofless
than about 5 pg/l. Key works. arsenate, arsenic, arsenite, dimethylarsinic, intercomparison,
monomethylarsonic, speciation, urine. EnvironHealthPerspect105:650-653 (1997)
An intercomparison exercise was sponsored
by the Electric Power Research Institute
(EPRI) for the quantification of arsenic
species in spiked human urine. The primary
objective of the exercise was to determine
the variance among laboratories in the
analysis ofarsenic species such as inorganic
As (As+3 and As+:), monomethylarsonic
acid (MMA), and dimethylarsinic acid
(DMA). Only laboratories with previous
experience with arsenic speciation analysis
participated. The results in this report are
not identified byspecific laboratory.
Materials and Methods
Samples. A urine composite collected from
three adults was frozen, thawed, and
decanted to reduce the amount ofsuspend-
ed matter and then spiked with the concen-
trations of arsenic shown in Table 1. The
chemicals used to spike the urine included
sodium arsenite and sodium arsenate
(99.9% pure; Mallinckrodt, Phillipsburg,
NJ), methane arsonic acid (no purity given;
Ansul Inc., Marinette, WI), and sodium
cacodylate (no purity given; Ted Pella, Inc.,
Redding, CA). The unspiked urine con-
tained approximately 0.4 pg/l inorganic
arsenic, 0.5 pg/l MMA, and 2 pg/l DMA.
After the urine was spiked, approxi-
mately 200-ml aliquots were frozen in poly-
ethylene bottles and shipped on ice to seven
laboratories by air courier. Included in the
Table 1. Spiking concentrations for three urine
samples
Arsenic (pg/I)
Sample As+3 As+5 MMA DMA
1A 1.5 1.5 1.5 4.0
2A 4.0 2.0 6.0 15.6
3A 12.5 12.5 22.0 44.0
Abbreviations: MMA, monomethylarsonic acid;
DMA, dimethylarsinic acid.
shipments were standard solutions of 10
mg/l of MMA and DMA and 5 ml of
National Institute of Standards and
Technology (NIST; Gaithersburg, MD)
standard reference material (SRM) 2670
(toxic metals in human urine), which is
certified at 480 ± 100 pg/l total arsenic.
The shipping procedures were designed
to keep the urine samples frozen or cold for
about 48 hr. Thesamples wereshippedbyair
courier; however, three laboratories received
samples thatwere notcold (Table 2).
Analytical methods. Several different
types ofanalytical methods were used to spe-
ciate the arsenic in the urine samples (Table
3). Four laboratories used hydride-cryogenic
trap-atomic absorption spectroscopy (AAS),
two used ion exchange, and one used high-
performance liquid chromatography
(HPLC) to separate inorganic and organic
species. Only two laboratories (Numbers 4
and 7) determined As+3 and As+5. Because
these two laboratories used different meth-
ods, a limited comparison can be made for
inorganic speciation. The methods for the
determination of total arsenic included
inductively coupled plasma mass spectrome-
try (ICP-MS), extraction-graphite furnace
atomic absorption (GFAA), and digestion or
ashingfollowedbyhydride-AAS (Table 3).
The method detection limits [MDL;
defined as the minimum concentration ofa
Table 2. Condition ofsamples after shipment
Days in Condition when
Laboratory transit received
1 2 Warm
2 NR Frozen
3 10 Warm
4 8 Warm
5 NR Cold
6 NR Frozen
7 NR Frozen
NR, not reported.
substance that can be measured and reported
with 99% confidence that the analyte con-
centration is greater than zero and is deter-
mined from analysis of a sample in a given
matrix containing the analyte (1)] reported
by the participating laboratories are shown in
Table 4. Sample volumes used were not
reported. The laboratories were able to quan-
tify the arsenic species in all but a few cases
in the Sample IA, the lowest spike sample.
For each sample type and species of
arsenic, laboratories were compared using a
one-way analysis-of-variance (ANOVA) on
the natural logarithm transformed concen-
tration. The transformation was conducted
to reduce the inequality ofthe within-labo-
ratory variances.
Results and Discussion
Each of the seven laboratories analyzed
three types of samples: 1) known standard
solutions of MMA and DMA; 2) known
NIST SRM 2670; and 3) three spiked urine
samples of unknown concentration. In
most cases, the laboratories analyzed each
sample in triplicate.
Laboratories analyzed two known
methylated arsenic standard solutions that
were distributed with the urine samples.
These standards contained 10 ppm MMA
and 10 ppm DMA as arsenic. The purpose
was to determine whether there was bias
among laboratories due to the availability of
calibrating standards. The participating lab-
oratories analyzed these two standards for
either the methylated form and/or total
arsenic. The results (Table 5) indicate that
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all laboratories agree within ±19% on the
nominal concentration of the methylated
compounds. The three laboratories that
analyzed these two standards for total
arsenic were within ±15% of the nominal
value, except for one value of+37%.
The results for the analysis ofthe SRM
2670 for arsenic species are shown in Table
6. This reference material was prepared by
NIST by spiking inorganic arsenic into
urine. Therefore, more than 80% of the
arsenic is in the inorganic form. The mean
total arsenic of 509 pg/l reported by the
seven laboratories is in good agreement
with the certified value of 480 ± 100 pg/l.
Both MMA and DMA were quantified by
most laboratories. Laboratory Number 4
determined the inorganic arsenic to be
arsenate (As+5). The sum ofmean inorgan-
ic, MMA, and DMA was 487 pg/l, which
is 15 pg/l less than the total arsenic deter-
mined by AAS or ICP-MS. This difference
between total arsenic and the sum of the
arsenic species detected could be due to
other arsenic compounds in the urine that
were not detected by most ofthe speciation
methods used; methods for total arsenic
may not detect all species ofarsenic present
in a sample. Laboratory Number 4, using
HPLC-ICP-MS, reported approximately
30 pg/l ofarsenobetaine.
The results from the analysis of the
three spiked urine samples by the partici-
pating laboratories are shown in Table 7.
Each laboratory analyzed three replicates.
Total As (Table 7) refers to arsenic analyzed
by methods that quantify both inorganic
and organic arsenic; however, the effective-
ness of some of the total methods used on
very stable organic arsenic compounds, such
as arsenobetaine, is not known.
Sixlaboratories reported results for inor-
ganic arsenic, two laboratories reported
results for As+3 and As+5, seven laboratories
reported results for MMA and DMA, and
seven laboratories reported results for total
As. The mean concentration and coefficient
ofvariation (CV) for the results are shown
in Table 7 for each ofthe three spiked urine
samples.
The mean arsenic concentrations for
the seven laboratories are compared with
the concentrations ofarsenic species spiked
in Samples 1A, 2A, and 3A (Table 8). The
percentage recoveries (the ratio of mean
arsenic detected to concentratiorn spiked) in
Table 8 range from 33 to 155% in Sample
1A, the sample spiked with the lowest con-
centration of arsenic species. The percent-
age recoveries improve significantly for
Sample 2Aand Sample 3A.
Effectsfrom storageandshipping. Urine
samples were shipped frozen by air courier
on 8 August 1994. Three laboratories
Table3.Analytical methods used by each laboratory
Laboratory Methods for arsenic speciation Methodsfortotal arsenic
1 Hydride-cryogenic trap-AAS Wetdigestion, hydride-AAS
2 Ion exchange, toluene extraction, GFAA(inorganic) Toluene extraction, GFAA
Ion exchange, GFAA(MMA and DMA)
3 Hydride-cryogenic trap-AASa Extraction, GFAAb
4 HPLC-ICP-MS ICP-MS
5 Hydride-cryogenic trap-AAS Ashing with Mg(NO3)2, hydride-AAS
6 Ion exchange, hydride AASC Dry ashing, hydride-AASd
7 Hydride-cryogenic trap-AAS8 ICP-MS
Abbreviations: AAS, atomic absorption spectroscopy; GFAA, graphite furnace atomic absorption; MMA,
monomethylarsonic acid; DMA, dimethylarsinic acid; ICP-MS, inductively coupled plasma massspectrometry.
aFrom Howard and Comber (2).
bFrom Subramanian (5).
CFrom Tam et al.(3).
dFrom Vahter etal. (6).
8From Crecelius et al. (4).
Table 4. Method detection limits in units
Arsenic"
Laboratory Inorganic As As+3 As+5 MMA DMA Total As
1 1.5 - - 2.0 4.0 0.7
2 - - 0.8 2.5
3 1.2 - - 0.8 1.2 3.8
4 0.5 0.5 0.5 0.5 0.5 0.5
5 0.1 ng/l - - 0.1 ng/l 3.0 ng/l 1.0 ng/l
6 2.0 ng/l - - 2.0 ng/l 2.0 ng/l 2.0 ng/l
7 0.05 0.05 0.05 0.1 0.1 3.0
Abbreviations: MMA, monomethylarsonic acid; DMA, dimethylarsinic acid.
"Given as pg/liter exceptwhere ng/l is indicated.
Table 5. Concentrations of MMA and DMA determined in 10 ppm standard solutions as methylated
arsenic compound ortotal arsenic
Arsenic (mg/I)
MMAstandard (10 pm) DMA standard (10 ppm)
Laboratory MMA Total As DMA Total As
1 10.1 - 9.7 -
2 - - 11.9 9.9
3 9.2 13.7 10.4 8.5
4 - 9.23 - 10.4
5 9.6 - 10.3 -
6 8.5 - 9.1 -
7 11.2 9.7 9.5 10.7
Abbreviations: MMA, monomethylarsonic acid; DMA, dimethylarsinic acid.
Table6. Concentrations of arsenic species and total arsenic in NISTSRM 2670 urine sample (certified
value 480 ± 100 pg/l total arsenic)
Arsenic (pg/I)
Inorganic
Sample Laboratory Total inorganicAs" As+3 As+5 MMA DMA SumAsb Total Asc
SRM 2670 1 476 - - 22.7 - - 495
2 - - - - 54.8 - 432
3 417 - - 9.3 44.0 471 570
4 362 <1 362 16.7 60.0 439 475
5 431 - - 15.1 69.9 516 -
6 385 - - 14.7 38.7 438 486
7 509 - - 14.5 45.5 569 556
Mean 430 - - 15.5 52.2 487 502
CV 13% - - 28% 22% 11% 10%
Abbreviations: MMA, monomethylarsonic acid; DMA, dimethylarsinic acid; SRM, standard reference
material; CV, coefficientofvariation.
aTotal inorganic As includesAs+3 andAs+5.
bSum ofinorganic arsenic, MMA, and DMA.
'Total As determined by either atomic absorption or inductively coupled plasma-mass spectrometry.
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Diferences among analytical methods.
There does not appear to be a systematic
difference among analytical methods for
arsenic speciation based on this exercise
using four arsenic species spiked at between
1.5 and 44 pg/l. Fourlaboratories (Numbers
1, 3, 5, and 7) used hydride-cryogenic trap-
AAS. Laboratory Number 2, which used ion
exchange-GFAA, reported similar results for
Table 7. Concentrations ofarsenic species and total arsenic in urine samples
Arsenic (pg/I)
Inorganic
Sample Laboratory Total inorganic As" As+3 As+5 MMA DMA Sum Asb Total Asc
1A 1 2.7 - - 1.7d 8.3 12.7 15.1
2 - - - - 11.2 - 9.1
3 2.5 - - 1.4 7.6 11.4 9.9
4 1.6 1.6 <1.0 2.7 9.5 13.8 24.1
5 1.3 - - 1.3 8.1 10.8 17.9
6 2.1 - - 1.6 7.4 11.1 10.7
7 1.9 1.2 0.7 1.6 5.8 9.3 15.5
Mean 2.0 1.4 0.7 1.7 8.3 11.5 14.6
CV 26% 18% - 28% 20% 14% 36%
2A 1 5.1 - - 4.7 20.1 30.0 31.8
2 - - - - 18.6 - 28.4
3 5.0 - - 4.1 21.7 30.7 28.2
4 5.1 2.9 2.1 3.5 18.9 27.5 40.7
5 3.2 - - 4.3 22.3 29.8 37.6
6 6.0 - - 4.8 18.9 29.7 30.5
7 3.8 3.1 0.7 5.5 14.9 24.2 39.6
Mean 4.7 3.0 1.4 4.5 19.3 28.7 33.8
CV 21% 4% 73% 15% 13% 9% 16%
3A 1 30.0 - - 19.4 40.7 90.1 89.1
2 - - - - 39.1 - 89.8
3 29.7 - - 19.0 52.9 102.0 102.0
4 25.2 10.5 14.7 19.4 57.2 102.0 113.0
5 23.7 - - 18.1 56.1 97.9 107.0
6 28.2 - - 19.5 43.9 90.7 95.1
7 25.5 11.6 15.8 23.9 48.0 97.4 126.0
Mean 27.0 11.1 15.3 19.9 48.3 96.6 103.0
CV 10% 7% 5% 10% 15% 5% 13%
Abbreviations: MMA, monomethylarsonic acid; DMA, dimethylarsinic acid; CV, coefficient ofvariation.
aTotal inorganic As includes As+3 and As+5.
bSum of inorganic arsenic, MMA, and DMA.
cTotal As determined by either atomic absorption or inductively coupled plasma-mass spectrometry.
dResult is close tothe method detection limit.
Table 8. Mean concentrations of arsenic species
Arsenic (pg/I)
Inorganic
Total
Sample inorganic As" As+3 As+5 MMA DMA Sum Asb Total Asc
1A Lab mean 1.6 1.2 0.5 1.2 6.2 9.0 11.7
Concentration spiked 3.0 1.5 1.5 1.5 4.0 8.5 8.5
Percent recovery 53% 80% 33% 81% 155% 106% 138%
2A Lab mean 4.3 2.8 1.2 4.0 17.3 25.6 30.9
Concentration spiked 6.0 4.0 2.0 6.0 16.0 28.0 28.0
Percent recovery 72% 70% 60% 67% 108% 91% 110%
3A Lab mean 26.6 10.9 15.1 19.4 46.3 92.3 100.0
Concentration spiked 25.0 12.5 12.5 22.0 44.0 91.0 91.0
Percent recovery 106% 87% 121% 88% 105% 101% 110%
Abbreviations: MMA, monomethylarsonic acid; DMA, dimethylarsinic acid. The results have been cor-
rected for arsenic species in the unspiked urine.
,Total inorganic As includes As+3 andAs+5.
bSum of inorganic arsenic, MMA, and DMA.
cTotal As determined by either atomic absorption or inductively coupled plasma-mass spectrometry.
DMA. Laboratory Number 6, which used
ion exchange-hydride-AAS, reported con-
centrations similar to the mean for all labo-
ratories. Laboratory Number 4, which used
HPLC-ICP-MS, also reported results similar
to the mean.
There were no trends in statistical dif-
ferences found among laboratories based
on the ANOVA; that is, no laboratory
stood out in the analysis. Statistical differ-
ences (p<0.05) were found when the with-
in-laboratory variances were small com-
pared with the between-laboratory vari-
ance. Laboratory mean concentrations,
either high or low, were not consistent
across sample type or arsenic species.
Laboratories (Number 4 and Number 7)
reported results for As+3 and As+5 in spiked
samples 2A and 3A, which had been spiked
with detectable levels of these species. The
As+3 andAs+5 results forSample 3A were sim-
ilar for these two laboratories, and the mean
percentage recovered ranged from 87% for
As+3 to 121% for As+5, indicating that some
oftheAs+3 may have oxidized to As+5 during
storage or analysis (Table 8). Results for
Sample 2A had mean As+3 and As+5 recover-
ies of70% to 60%, respectively. There is no
indication that theoxidation ofAs+3 toAs+5 is
aserious problem forthese methods. Research
reported by Hughes et al. (7) demonstrated
that on-column oxidation ofAs+3 to As+5 can
occur under certain pH conditions using
some HPLC methods. However, they also
reported that an ion-pairing HPLC method
was developed for analysis ofAs+3, which
eliminated the oxidation ofAs+3.
An investigation of the stability of
arsenite was conducted by Laboratory
Number 4, which used HPLC for specia-
tion. They found that at the pH values of
6.0 and 3.75 in the mobile phase no on-col-
umn oxidation occurred. At values above
pH 10, some oxidation was observed after 1
hr, and at pH 13, halfthe arsenite was oxi-
dized to arsenate during the analysis.
Conclusions
The results of this interlaboratory compari-
son are encouraging. There is relativelygood
agreement on the concentrations of three
arsenic species (inorganic arsenic, MMA,
and DMA) in urine at concentrations that
are relevant to research on the metabolism
of arsenic in humans and other mammals.
Both the accuracy and precision are relative-
ly poor for arsenic concentrations of less
than about 5 pg/l because the method detec-
tion limits for some ofthe laboratories are in
the range of 1-5 pg/l. Because only two lab-
oratories reported results for arsenite and
arsenate, additional intercomparisons are
needed to evaluate comparability of labora-
tories for these species.
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received samples that were at room temper-
ature and that had been in transit for 2-10
days. All samples were analyzed during
August and September 1994. There is no
indication that the shipping procedures
affected the arsenic speciation. The results
for the laboratories that received warm sam-
ples are similar to those from laboratories
that received cold or frozen samples.
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The conference Risk 97will be held October 21-24, 1997, in Amsterdam and is organized by RIVM, in coop-
eration with various international organizations. The central theme ofthe conferencewill be the relevance of
geographical maps forthe discussion on and the managementof risks. Risk concepts weredeveloped in vari-
ous, widelydiffering fields of science and policy. Within the environmental sciences, differences in approach
can also be distinguished, e.g., between radiological risks, risks ofcarcinogenic compounds, and ecotoxico-
logical risks. Whereas the assessment of radiological risks for humans is largely regulated, the methods for
assessing risks oftoxic compounds for humans and the ecosystem are still developing. However, in all these
disciplines the application ofgeographical information and transferring estimated riskvalues into maps are
emerging. Although the aimsof riskassessments in each ofthese fields are similar, the terminologyand the
methods differwidely, which creates profound difficulties in policy making and negotiationswith the parties
involved, such as industries and the public. The conference aims to bring these subjects together to advance
mutual understanding and thetechnologyof risk mapping.
Ifyou are interested in attending the Conference or ifyou wantto submit an abstractfor an oral presentation
or a poster, contact:
RISK 97Conference Secretariat
GEOPLAN, Emmastraat 28, 1075 HVAmsterdam
Fax +31 20 - 66463 06
E-mail: risk97.rivm@geoplan.nl
http://www.risk97.rivm.nl/
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